Targeting the androgen receptor signaling axis to reduce testosterone levels in prostate cancer: how low should we go?

Oncology (Williston Park). 2014 Aug;28(8):700-1.
No abstract available

Publication types

  • Comment

MeSH terms

  • Androgen Antagonists / therapeutic use*
  • Humans
  • Male
  • Prostatic Neoplasms, Castration-Resistant / drug therapy*
  • Receptors, Androgen / physiology*

Substances

  • AR protein, human
  • Androgen Antagonists
  • Receptors, Androgen